These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17961828)

  • 1. Mechanism-of-action determination of GMP synthase inhibitors and target validation in Candida albicans and Aspergillus fumigatus.
    Rodriguez-Suarez R; Xu D; Veillette K; Davison J; Sillaots S; Kauffman S; Hu W; Bowman J; Martel N; Trosok S; Wang H; Zhang L; Huang LY; Li Y; Rahkhoodaee F; Ransom T; Gauvin D; Douglas C; Youngman P; Becker J; Jiang B; Roemer T
    Chem Biol; 2007 Oct; 14(10):1163-75. PubMed ID: 17961828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into the antifungal drug target guanosine monophosphate synthase from Aspergillus fumigatus.
    Nguyen S; Jovcevski B; Pukala TL; Bruning JB
    Acta Crystallogr D Struct Biol; 2022 Feb; 78(Pt 2):248-259. PubMed ID: 35102890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional basis of mycophenolic acid resistance in Candida albicans IMP dehydrogenase.
    Köhler GA; Gong X; Bentink S; Theiss S; Pagani GM; Agabian N; Hedstrom L
    J Biol Chem; 2005 Mar; 280(12):11295-302. PubMed ID: 15665003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum differentially alters the antifungal properties of echinocandin drugs.
    Paderu P; Garcia-Effron G; Balashov S; Delmas G; Park S; Perlin DS
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2253-6. PubMed ID: 17420211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and optimization of in vitro assay conditions for (1,3)beta-glucan synthase activity from Aspergillus fumigatus and Candida albicans for enzyme inhibition screening.
    Wood RL; Miller TK; Wright A; McCarthy P; Taft CS; Pomponi S; Selitrennikoff CP
    J Antibiot (Tokyo); 1998 Jul; 51(7):665-75. PubMed ID: 9727393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel assay for fungal ketol-isomerase activity.
    Nakata M; O'Rourke R; Wilson S; Chilson K; Selitrennikoff CP
    J Antibiot (Tokyo); 2001 Sep; 54(9):737-43. PubMed ID: 11714230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
    Ikegami T; Natsumeda Y; Weber G
    Adv Exp Med Biol; 1989; 253B():299-304. PubMed ID: 2575350
    [No Abstract]   [Full Text] [Related]  

  • 8. Fungistatic activity of all-trans retinoic acid against Aspergillus fumigatus and Candida albicans.
    Campione E; Gaziano R; Marino D; Orlandi A
    Drug Des Devel Ther; 2016; 10():1551-5. PubMed ID: 27199548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new isoxazoles and dihydroisoxazoles and in vitro evaluation of their antifungal activity.
    Chevreuil F; Landreau A; Séraphin D; Larcher G; Mallet S; Bouchara JP; Richomme P
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):563-9. PubMed ID: 18035824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Zinc-Attenuating Compounds as Potent Broad-Spectrum Antifungal Agents with
    Cohrt KAO; Marín L; Kjellerup L; Clausen JD; Dalby-Brown W; Calera JA; Winther AL
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. I. Taxonomy, fermentation, isolation, and biological activities.
    Yano T; Aoyagi A; Kozuma S; Kawamura Y; Tanaka I; Suzuki Y; Takamatsu Y; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2007 Feb; 60(2):136-42. PubMed ID: 17420564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Leptospermum petersonii essential oil on Candida albicans and Aspergillus fumigatus.
    Hood JR; Burton DM; Wilkinson JM; Cavanagh HM
    Med Mycol; 2010 Nov; 48(7):922-31. PubMed ID: 20446888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products.
    Jiang B; Xu D; Allocco J; Parish C; Davison J; Veillette K; Sillaots S; Hu W; Rodriguez-Suarez R; Trosok S; Zhang L; Li Y; Rahkhoodaee F; Ransom T; Martel N; Wang H; Gauvin D; Wiltsie J; Wisniewski D; Salowe S; Kahn JN; Hsu MJ; Giacobbe R; Abruzzo G; Flattery A; Gill C; Youngman P; Wilson K; Bills G; Platas G; Pelaez F; Diez MT; Kauffman S; Becker J; Harris G; Liberator P; Roemer T
    Chem Biol; 2008 Apr; 15(4):363-74. PubMed ID: 18420143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization and virulence study of ADE8 and GUA1 genes involved in the de novo purine biosynthesis in Candida albicans.
    Jiang L; Zhao J; Guo R; Li J; Yu L; Xu D
    FEMS Yeast Res; 2010 Mar; 10(2):199-208. PubMed ID: 20082641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
    Hofer A; Steverding D; Chabes A; Brun R; Thelander L
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6412-6. PubMed ID: 11353848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on antifungal agents. 20. Effect of the nitrogen substitution on the in vitro activity of novel 3,5-substituted isoxazolidines.
    Swift PA; Mullen GB; Mitchell JT; Allen SD; St Georgiev V
    Chemotherapy; 1989; 35(2):130-2. PubMed ID: 2667902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of chitin synthase 2 and antifungal activity of lignans from the stem bark of Lindera erythrocarpa.
    Hwang EI; Lee YM; Lee SM; Yeo WH; Moon JS; Kang TH; Park KD; Kim SU
    Planta Med; 2007 Jun; 73(7):679-82. PubMed ID: 17538872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
    Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.